Transcription factor FOXO3a controls the persistence of memory CD4+ T cells during HIV infection

被引:0
作者
Julien van Grevenynghe
Francesco A Procopio
Zhong He
Nicolas Chomont
Catherine Riou
Yuwei Zhang
Sylvain Gimmig
Genevieve Boucher
Peter Wilkinson
Yu Shi
Bader Yassine-Diab
Elias A Said
Lydie Trautmann
Mohamed El Far
Robert S Balderas
Mohamed-Rachid Boulassel
Jean-Pierre Routy
Elias K Haddad
Rafick-Pierre Sekaly
机构
[1] Laboratoire d'Immunologie,Département de Microbiologie et d'Immunologie
[2] Centre de Recherche,Immunodeficiency Service and Division of Haematology
[3] Hôpital Saint-Luc,Department of Microbiology and Immunology
[4] Centre Hospitalier de l'Université de Montréal,undefined
[5] Laboratoire d'Immunologie,undefined
[6] Université de Montréal,undefined
[7] Institut national de la Santé et de la Recherche médicale U743,undefined
[8] Centre de Recherche,undefined
[9] Centre Hospitalier de l'Universite de Montréal,undefined
[10] BD Biosciences,undefined
[11] Royal Victoria Hospital,undefined
[12] McGill University Health Center,undefined
[13] McGill University,undefined
[14] McGill University,undefined
来源
Nature Medicine | 2008年 / 14卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The persistence of central memory CD4+ T cells (TCM cells) is a major correlate of immunological protection in HIV/AIDS, as the rate of TCM cell decline predicts HIV disease progression. In this study, we show that TCM cells and effector memory CD4+ T cells (TEM cells) from HIV+ elite controller (EC) subjects are less susceptible to Fas-mediated apoptosis and persist longer after multiple rounds of T cell receptor triggering when compared to TCM and TEM cells from aviremic successfully treated (ST) subjects or from HIV− donors. We show that persistence of TCM cells from EC subjects is a direct consequence of inactivation of the FOXO3a pathway. Silencing the transcriptionally active form of FOXO3a by small interfering RNA or by introducing a FOXO3a dominant-negative form (FOXO3a Nt) extended the long-term survival of TCM cells from ST subjects to a length of time similar to that of TCM cells from EC subjects. The crucial role of FOXO3a in the survival of memory cells will help shed light on the underlying immunological mechanisms that control viral replication in EC subjects.
引用
收藏
页码:266 / 274
页数:8
相关论文
共 50 条
[1]  
Kaech SM(2002)Effector and memory T cell differentiation: implications for vaccine development Nat. Rev. Immunol. 2 251-262
[2]  
Wherry EJ(2004)Central memory and effector memory T cell subsets: function, generation, and maintenance Annu. Rev. Immunol. 22 745-763
[3]  
Ahmed R(2006)T cell memory and protective immunity by vaccination: is more better? Trends Immunol. 27 511-517
[4]  
Sallusto F(2006)Central memory CD4 T cells are the predominant cell subset resistant to anergy in SIV disease resistant sooty mangabeys AIDS 20 181-188
[5]  
Geginat J(2003) analysis of human memory CD4 T cells specific for hepatitis C virus using MHC class II tetramers J. Clin. Invest. 112 831-842
[6]  
Lanzavecchia A(2006)Preserved CD4· central memory T cells and survival in vaccinated SIV-challenged monkeys Science 312 1530-1533
[7]  
Zanetti M(2007)Progressive CD4· central memory T cell decline results in CD4. effector memory insufficiency and overt disease in chronic SIV infection J. Exp. Med. 204 2171-2185
[8]  
Franchini G(1995)Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection N. Engl. J. Med. 332 201-208
[9]  
Bostik P(1996)Cytotoxic T lymphocytes in asymptomatic long-term nonprogressing HIV-1 infection. Breadth and specificity of the response and relation to J. Immunol. 156 2616-2623
[10]  
Day CL(2003) viral quasispecies in a person with prolonged infection and low viral load Biochem. Soc. Trans. 31 292-297